← All Companies
SWK Holdings Corp
SWKH · Nasdaq · SIC 6159: Miscellaneous Business Credit Institution
Business Summary SWK Holdings Corporation is a specialty finance and asset management company focused on healthcare and life sciences. Through its Finance Receivables segment, it provides customized financing solutions including royalty purchases, synthetic revenue interests, and secured debt to life science companies, institutions, and inventors. The company previously operated a Pharmaceutical Development segment (MOD3 Pharma/Enteris BioPharma) providing drug development, formulation, and manufacturing services, which was sold in Q3 2025. Headquartered in Dallas, Texas, SWK targets sub-$50 million transactions in biotechnology, medical devices, diagnostics, animal health, and pharmaceuticals.
Next Earnings Q2 FY2026 — expected 2026-09-20
Key Facts from Earnings Calls Type Subject Detail Quarter topic_mention SWKH discussed_in_filing Cybersecurity topic_mention SWKH discussed_in_filing Trusted Computing topic_mention SWKH discussed_in_filing Blockchain & Crypto topic_mention SWKH discussed_in_filing Regulation topic_mention SWKH discussed_in_filing Automotive topic_mention SWKH discussed_in_filing Healthcare & Bio topic_mention SWKH discussed_in_filing Sovereign & Government topic_mention SWKH discussed_in_filing Cybersecurity topic_mention SWKH discussed_in_filing Trusted Computing topic_mention SWKH discussed_in_filing Blockchain & Crypto topic_mention SWKH discussed_in_filing Regulation topic_mention SWKH discussed_in_filing Automotive topic_mention SWKH discussed_in_filing Healthcare & Bio topic_mention SWKH discussed_in_filing Sovereign & Government topic_mention SWKH discussed_in_filing Cybersecurity topic_mention SWKH discussed_in_filing Trusted Computing topic_mention SWKH discussed_in_filing Blockchain & Crypto topic_mention SWKH discussed_in_filing Regulation topic_mention SWKH discussed_in_filing Automotive topic_mention SWKH discussed_in_filing Healthcare & Bio
Annual Reports (10-K) Filed Period Accession Source Full Text 2026-03-20 2025-12-31 0001089907-26-000004 EDGAR 51K words 2025-03-20 2024-12-31 0001628280-25-013989 EDGAR — 2024-03-20 2023-12-31 0001552781-24-000162 EDGAR — 2023-03-31 2022-12-31 0001552781-23-000219 EDGAR — 2022-03-25 2021-12-31 0001552781-22-000279 EDGAR — 2021-03-31 2020-12-31 0001552781-21-000167 EDGAR — 2020-03-30 2019-12-31 0001552781-20-000237 EDGAR — 2019-03-28 2018-12-31 0001552781-19-000124 EDGAR — 2018-03-29 2017-12-31 0001552781-18-000138 EDGAR — 2017-03-17 2016-12-31 0001552781-17-000140 EDGAR —
Quarterly Reports (10-Q) Filed Period Accession Source Full Text 2025-11-06 2025-09-30 0001628280-25-050155 EDGAR 21K words 2025-08-14 2025-06-30 0001628280-25-040420 EDGAR — 2025-05-15 2025-03-31 0001628280-25-025955 EDGAR — 2024-11-14 2024-09-30 0001628280-24-047908 EDGAR — 2024-08-14 2024-06-30 0001552781-24-000488 EDGAR — 2024-05-15 2024-03-31 0001552781-24-000343 EDGAR — 2023-11-08 2023-09-30 0001552781-23-000439 EDGAR — 2023-08-10 2023-06-30 0001552781-23-000359 EDGAR — 2023-05-10 2023-03-31 0001552781-23-000266 EDGAR — 2022-11-09 2022-09-30 0001552781-22-000629 EDGAR — 2022-08-10 2022-06-30 0001552781-22-000529 EDGAR — 2022-05-10 2022-03-31 0001552781-22-000390 EDGAR —
Recent Current Reports (8-K) Filed Accession Source Full Text 2026-04-06 0001552781-26-000198 EDGAR 3K words 2026-03-31 0001552781-26-000183 EDGAR — 2026-02-13 0001628280-26-008158 EDGAR — 2025-12-05 0001628280-25-055596 EDGAR — 2025-12-04 0001552781-25-000439 EDGAR — 2025-11-06 0001628280-25-050153 EDGAR — 2025-10-10 0001552781-25-000317 EDGAR — 2025-10-09 0001552781-25-000315 EDGAR — 2025-10-01 0001628280-25-043460 EDGAR — 2025-08-14 0001628280-25-040422 EDGAR —
416 total filings indexed. 384 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers Tags biotechnology pharmaceuticals medical-devices medical-diagnostics life-science-tools animal-health specialty-finance-/-healthcare-capital
Company Identity
CIK 0001089907
Ticker SWKH
Exchange Nasdaq
SIC 6159: Miscellaneous Business Credit Institution
Incorporated DE
Headquarters Dallas, Texas
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 242ab671156bcb716d236b9c3d50c23eaccb723c3e296870164ed28e93b4441b
parent: befed2276f7ab53b3e9d13638f6352f8d7039d33aabd2c818af7444cae77839d
content hash: f0bcffd6c2db02a3bf5c64bcea3c15a60109b2afccca96deefa49489c60e08e6
signed: 2026-04-13T04:47:41.585Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf